Content Type: Article

  • Absent Proof of Government Ownership on an EEA Sovereign Immunity Defense is All Black and White

    Absent Proof of Government Ownership on an EEA Sovereign Immunity Defense is All Black and White

    ARTICLE

    Absent proof of government ownership on an EEA sovereign immunity defense is all black and white

    August 5, 2021

    Read time: 7 min

    The US Court of Appeals for the Ninth Circuit affirmed the district court’s denial of a motion to dismiss an indictment, charging four Chinese companies with violations of the criminal provisions of the Economic Espionage Act (EEA) and finding no sovereign immunity under the Foreign Sovereign Immunities Act (FSIA) in view of the defendant’s commercial activities and failure of proof. United States of America v. Pangang Group Company Ltd. et al., Case No. 19-10306 (9th Cir. July 26, 2021) (Collins, J.)

    No company in China had been able to develop a clean and efficient technology to produce titanium dioxide, a white pigment used in products such as paints, sunscreen, lotions, paper and plastics. A group of related Chinese steel companies (collectively, the Pangang companies) wanted to obtain such technology.

    In the United States, after many years of research and development, DuPont had managed to develop a process to produce titanium dioxide and was unwilling to sell or license the technology to Chinese companies. Chinese government officials approached US businessman and former DuPont research engineer Walter Liew to obtain DuPont’s trade secrets. Liew agreed to become a corporate spy and managed to gain access to DuPont’s technology. Liew unlawfully transferred the trade secrets to the Pangang companies. The Pangang companies also conspired with unknown computer hackers to access DuPont’s computers to further steal DuPont’s trade secrets.

    The Pangang companies were indicted on one count of conspiring to commit economic espionage for the benefit of a foreign government or instrumentality to steal DuPont’s trade secrets and one count of attempting to commit such economic espionage in violation of the EEA. The Pangang companies pleaded not guilty and moved to dismiss a criminal indictment for violations of the EEA, arguing that they were “instrumentalities” of the government of the People’s Republic of China (PRC) and were entitled to sovereign immunity under the FSIA. The district court denied the motion, holding that the Pangang companies were not immune in light of the FSIA’s commercial activity and waiver exceptions. The Pangang companies appealed.

    The Ninth Circuit found that the Pangang companies failed to show that they were instrumentalities of a foreign sovereign within the meaning of the FSIA. For a company to be considered a foreign instrumentality under FSIA, a government must own the majority shares in the company. The indictment included several allegations about the ownership structure of the Pangang companies. The indictment alleged that the Pangang Group Company was a “state-owned enterprise controlled by the State-Owned Assets Supervision and Administration Commission of the State Council” (SASAC), a “special government agency” of the PRC. The other Pangang companies were alleged to be direct or indirect “subsidiaries” of the Pangang Group Company. The Ninth Circuit found that the allegations, taken as true, affirmatively negated the premise that the other Pangang companies could be considered agencies or instrumentalities of the PRC because the indictment described all three of these entities as being “subsidiaries” of the fourth defendant (i.e., the Pangang Group Company). Because the corporate law concept of a “subsidiary” refers to a company in which the parent “has a controlling share,” the other companies were not directly owned by the foreign state and could not be an instrumentality of a foreign state.

    As to the ownership structure of the Pangang Group Company, the indictment alleged that “at all times relevant” the Pangang Group Company was a “state-owned enterprise controlled by SASAC.” The Ninth Circuit found the allegations insufficient to establish a prima facie case that the Pangang Company was an agency or instrumentality of the SASAC because an allegation of “controlled-by” is not enough. The crucial question is whether a “majority of the Pangang Company’s shares or other ownership interest is owned” by SASAC or the PRC. The Court concluded that because the Pangang companies relied solely upon allegations in the indictment and presented no evidence to support their motion to dismiss, they necessarily failed to establish a prima facie case that they were a “foreign state” entitled to immunity under FSIA.

    Authors

    Jodi Benassi

    Partner

    San Francisco

    More insights

  • Five Financing Challenges in European Healthcare Private Equity in 2021 and Beyond

    Five Financing Challenges in European Healthcare Private Equity in 2021 and Beyond

    ARTICLE / CLIENT ALERT

    Five Financing Challenges in European Healthcare Private Equity in 2021 and Beyond

    August 4, 2021

    Read time: 7 min

    Key takeaways
    Overview

    After a year during which uncertainty in the equity markets became the new normal, many stakeholders are wondering whether the disruptions are behind us. A look at key indicators might lead one to say yes. The S&P Loan Index has returned to pre-pandemic levels, the default rate is significantly below the peak of 10% seen during the great financial crisis, and roughly $840 billion of M&A value was realized in 2020 versus $802 billion in 2019—and $290 million in Q1 2021 alone. But under the surface, several COVID-19-related factors and other market shifts still have the potential to lead to second-order or longer-term impacts.

    In depth

    Zombie Companies

    Governments in the European Union and the United Kingdom have injected an unprecedented amount of stimulus into the European economy, and there are still plenty of credits propped up by government stimulus and liquidity injections from both lenders and sponsors. It remains to be seen whether those companies can recover. A risk remains that a large cohort of “zombie companies” will never recover, and that liquidity may have gone to waste.

    Although currently healthcare businesses remain focused on having the cash to get through the pandemic, balance sheet sustainability will likely return to the fore, along with a reckoning that businesses that haven’t yet reopened are not likely to do so.

    But businesses that were negatively impacted and can successfully come back to the market may present an opportunity, with low valuations, to deploy capital and create value through buying at a discount.

    COVID Cash

    The phenomena of businesses that benefited by supporting efforts to combat COVID-19 is unlike anything the corporate market has seen before. There were no similar phenomena during the global financial crisis, when the dot-com bubble burst, or after the debt malaise of the early 1990s. In the COVID-19 era, however, companies in subsectors such as diagnostics, therapeutics and temperature-controlled logistics are likely to be sitting on piles of cash. Unfortunately, that cash is dissimilar to revenues made running a business in normal operating environments. “COVID cash” doesn’t have EBITDA or private equity value. In the current zero interest rate environment, debt is cheap if you need to deliver it or extend that cash. And cash has a zero return. As a result, accretion dilution analyses are entirely different than at any time in history.

    On the other hand, companies in subsectors such as medical devices, orthopedics, stents and peripherals are likely to have had a terrible experience during COVID-19 because discretionary surgeries were pushed into the future.

    The challenge today is to normalize company performance. Doing so requires corporate management to be credible and transparent regarding whether the company has had a good year and that status is temporary, or whether the company is in a position such that increased or decreased revenue will continue. Seeking the most realistic picture, investors are now predominantly pricing off year-end 2021 and walking away from partners and sellers that continue to advance non-sustainable COVID-19 revenue scenarios.

    Liquidity Gaps

    One of the biggest structural shifts in the market is in liquidity sources for borrowers. For the most part, direct lending funds have taken a very pragmatic approach. But banks have not been able to do the same and ultimately have completely retrenched from the market. For example, banks might have once had an appetite to look at super senior pieces or bifurcated structures, but they have ceased to do so during the last 12 to 18 months. Many banks and other traditional lenders have been overburdened with liquidity requests and thus may not have been able to deploy focus in other directions.

    The European Banking Group is also likely to face a large book of nonperforming loans in 2022. It remains to be seen how they will react, and what their appetite to new lending will be in that environment. This retrenchment may signal a longer-term structural shift, and it may be quite a while before banks come back into the market for private equity transactions in a meaningful way.

    On a positive note, efforts to plug liquidity gaps have resulted in more collaboration among private equity sponsors, borrowers and lenders, a trend that may continue in the long term.

    Looking for Longevity

    COVID-19 accelerated innovation and ushered many assets to market. The challenge moving forward into the next investment cycles is to determine which assets represent fads and therefore should be avoided, and which assets have longevity.

    The influx of new healthcare ideas in 2020 is ultra-fragmented and competitive. Although many of those assets realized significant revenue over the last 18 months, they are still several years away from being “ready for primetime” with a track record that supports long-term viability.

    Evolving Emphasis on ESG

    Beyond the pandemic effects, evolving environmental, social and governance (ESG) criteria are presenting new challenges for the market, with Europe seeing the greatest impacts.

    ESG criteria started in the large-cap syndicated space, filtered down into the mid-market space and now feature in the majority of deals. Although ESG has been a focus in Europe for some time, focus has historically centered upon internal governance. The shift now is to examine what primary debt lenders can do to actively promote ESG in the businesses in which they invest.

    With ESG considerations top of mind for investors and limited partners, sponsors and lenders are increasingly applying ESG factors as part of their risk mitigation and growth opportunity analysis process. It is becoming more common to see incentives proactively put in place to ensure that all parties are working towards the same ESG targets.

    Increasing ESG attention is also the result of a growing number of EU regulations designed to ensure that financing flows to more sustainable businesses in support of achieving the Paris targets, reducing carbon footprints and reversing climate change. Sponsors and lenders are seeking data to demonstrate net zero progress and commitments.

    One of the greatest challenges is that ESG is reactive to legislation on a country-by-country basis. What is deemed a recommendation versus what is mandatory, particularly in the case of cross-border transactions, is changing rapidly, and the evolution of requirements and expectations is largely outside corporate control.

    Looking Forward

    One of the most promising developments to come out of the pandemic was a recognition that meeting challenges on this scale requires operating with a greater level of collaboration. Partners on both sides of deals benefited from the increased information flow that occurred over the last 18 months. A more collaborative partnership model made it easier to get things done to the benefit of all parties during COVID-19, and has the potential to continue to do so.

    The analysis presented in this article stems from McDermott’s HPE Europe 2021 virtual conference and our sessions examining the current challenges in healthcare private equity. McDermott partners Grégoire Andrieux, Mark Fine, Aymen Mahmoud and Eleanor West served as session moderators, joined by industry professionals Adam Dolder of Great Point Partners, Brian Sheridan of Archimed, Holly Bott of Axis Arbor, Alex Jones of Ares, Michael Massarano of Arcmont Asset Management and Malin Hedman of Bain Capital Credit.

    Access the panel recordings, and further key takeaways, on our HPE Europe 2021 event website.

    Subscribe to our insights to stay abreast of trends and developments in the healthcare private equity market, and keep an eye out for HPE Europe 2022, which promises to be an exciting return to our exclusive in-person event.

    Authors

    Mark Fine

    Partner

    London – 22 Bishopsgate

    Aymen Mahmoud

    Partner

    London – 22 Bishopsgate

    Eleanor West

    Partner

    London – 22 Bishopsgate

    More insights

  • The Mahanoy Area School District Supreme Court Decision: Impact on Private Schools

    The Mahanoy Area School District Supreme Court Decision: Impact on Private Schools

    ARTICLE / CLIENT ALERT

    The Mahanoy Area School District Supreme Court Decision: Impact on Private Schools

    August 4, 2021

    Read time: 5 min

    Key takeaways
    Overview

    On June 23, 2021, the United States Supreme Court (“Court”) ruled 8-1 that a Pennsylvania public high school violated a student’s First Amendment free speech rights by disciplining her for sharing a profane critique of her school’s cheerleading team on social media.

    Brandi Levy, a Mahanoy Area High School student, was frustrated by her failure to make her school’s varsity cheerleading team. Outside of school hours and from an off-campus location, she transmitted vulgar language and gestures criticizing the school and its cheerleading team. Levy took a photo of herself and her friend raising their middle fingers, captioned “F*** school f*** softball f*** cheer f*** everything.” Levy posted the image to Snapchat, where it was visible to approximately 250 people, including fellow students and cheerleaders. The cheerleading coaches learned of Levy’s post and suspended her from the team for one year after deeming the posts in violation of team and school rules, which required cheerleaders to have “respect for [their] school, coaches, teachers, [and] other cheerleaders,” and to avoid “foul language and inappropriate gestures.” The public school board affirmed Levy’s suspension from the team.

    Levy’s parents filed suit against the public school district, alleging that Levy’s suspension from the team amounted to a violation of her First Amendment rights. A Pennsylvania federal district court found for Levy. The Third Circuit Court of Appeals affirmed, ruling that Tinker v. Des Moines Independent Community School District — a 1969 Supreme Court case holding that public schools could punish student speech that substantially disrupted the school community — did not apply to off-campus speech.

    The Supreme Court affirmed the Third Circuit’s holding, but rejected the conclusion that Tinker does not apply to off-campus speech. Declining to adopt a bright-line rule that schools cannot regulate student speech that takes place off-campus, the Court emphasized three features that diminish public schools’ authority to regulate off-campus speech. First, public schools have a diminished interest in regulating student speech when the school does not stand in loco parentis, or in the place of parents. The Court noted that in relation to off-campus speech, schools will rarely stand in loco parentis because such speech is typically within the purview of parental, rather than school-related, supervision. Second, when paired with on-campus regulations, off-campus regulations of speech could potentially be all-encompassing and prevent students from “engag[ing] in that kind of speech at all,” consequently requiring schools to meet a heavier burden to justify regulation. Third, the Court noted that public schools are “nurseries of democracy” and that unpopular opinions uttered off-campus should be protected in order to foster the marketplace of ideas upon which democracy depends.

    The Court identified several examples where schools maintain a significant interest in regulating off-campus speech, such as: “serious or severe bullying or harassment targeting particular individuals; threats aimed at teachers or other students; the failure to follow rules concerning lessons, the writing of papers, the use of computers or participation in other online school activities; and breaches of school security devices, including material maintained within school computers.” The Court stated that it is “uncertain as to the length or content of any … list of appropriate exceptions as carveouts,” particularly given the advent of computer-based learning. The Court also indicated that the list may change depending on the student’s age, the type of off-campus activity or the impact on the school itself.

    Although Mahanoy is not binding on private schools, private schools should carefully reconsider whether, in light of this Supreme Court decision, they should alter their approach to discipline of students for off-campus speech. For example, the Court noted that the posts appeared outside of school hours from a location outside the school; Levy did not identify the school in her posts or target any members of the school community with vulgar or abusive language; and she transmitted the message through a personal cellphone to an audience consisting of her private circle of Snapchat friends. Many private schools have been confronted by angry parents who do not understand that the First Amendment does not apply to private educational institutions and question why the school is taking disciplinary action relating to off-campus social media posts. While private schools have broad authority to set rules and discipline their students, in light of Mahanoy Area School District, private schools should review their social media and disciplinary policies and consider limiting discipline to conduct which has a significant impact on the school community and which the school has a significant interest in regulating.

    Authored by Mark E. Brossman and Donna K. Lazarus.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2021 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Mark E. Brossman

    Partner

    New York – 919 Third Avenue

    Donna K. Lazarus

    Partner

    New York – 919 Third Avenue

    More insights

  • Reminder: NFA Member Managers and Virtual Currency Disclosures

    Reminder: NFA Member Managers and Virtual Currency Disclosures

    ARTICLE / CLIENT ALERT

    Reminder: NFA Member Managers and Virtual Currency Disclosures

    August 4, 2021

    Read time: 7 min

    Key takeaways
    Overview

    As an increasing number of investment managers are exploring virtual currency spot and derivative trading as part of their investment programs, managers who are members of the National Futures Association (“NFA”) should be reminded that NFA Interpretive Notice 9073[1] requires special disclosures to fund participants and managed account clients in connection with virtual currency trading activities (“Virtual Currency Disclosures”).

    Who Must Deliver, and Receive, NFA Virtual Currency Disclosures?

    The NFA’s Virtual Currency Disclosures apply only to NFA-member managers. Commodity pool operators (“CPOs”) and commodity trading advisors (“CTAs”) who are not NFA members (for example, fully exempt managers relying on Rule 4.13(a)(3)) are not subject to these rules.[2]

    For those firms that are NFA members, all pools and accounts are covered by the Virtual Currency Disclosure Rules, i.e., NFA-member CPOs and CTAs must provide Virtual Currency Disclosures to all fund participants and account clients of:

    • Reportable commodity pools (e.g., commodity pools under Rule 4.7 relief);
    • Exempt pools (e.g., those under Rule 4.13(a)(3)) relief; and
    • Managed accounts;

    that engage in either spot/underlier or virtual currency derivative trading (“Virtual Currency Trading”). Note that “funds of funds” that are exposed to Virtual Currency Trading by virtue of investing in funds with such exposure are also covered by the NFA’s Virtual Currency Disclosures requirement.[3]

    Participants in an existing fund or separately managed account that will begin engaging in Virtual Currency Trading should be provided with Virtual Currency Disclosures at or before the time such fund or account engages in Virtual Currency Trading. Prospective investors should be provided with such disclosures prior to their participation in an investment vehicle or managed account that engages, or will engage, in Virtual Currency Trading.

    What Materials Do the NFA’s Virtual Currency Disclosures Affect?

    The NFA’s rules require fulsome risk disclosures in fund offering memoranda and managed-account brochures where the investment program includes Virtual Currency Trading. Short-form virtual currency disclosures must also be included in any promotional materials for these funds or accounts. The exact content of these disclosures will differ depending on the specific course of investment.[4]

    Spot trading in virtual currency

    NFA member CPOs and CTAs engaging in underlying or spot virtual currency transactions in a fund or managed account must “prominently” display a particular short-form “boilerplate” disclosure in both 1) promotional materials (such as investor marketing decks) and 2) offering memoranda or account brochures for this fund or account:

    [Name of NFA member] is a member of NFA and is subject to NFA’s regulatory oversight and examinations. [Name of NFA member] has engaged or may engage in underlying or spot virtual currency transactions in a [commodity pool or managed account program]. Although NFA has jurisdiction over [name of NFA member] and its [commodity pool or managed account program], you should be aware that NFA does not have regulatory oversight authority for underlying or spot market virtual currency products or transactions or virtual currency exchanges, custodians or markets. You should also be aware that given certain material characteristics of these products, including lack of a centralized pricing source and the opaque nature of the virtual currency market, there currently is no sound or acceptable practice for NFA to adequately verify the ownership and control of a virtual currency or the valuation attributed to a virtual currency by [name of NFA member].

    In addition to the above boilerplate disclosure, each applicable offering memorandum or brochure must also include a full discussion of risk factors “that are applicable to their [spot/underlier Virtual Currency Trading] activities[].” In particular, NFA Interpretive Notice 9073 highlights and discusses the following risk factors as topics to address[5]:

    • Unique features of virtual currencies
    • Price volatility issues
    • Valuation and liquidity issues
    • Cybersecurity considerations
    • The opaqueness of the spot market
    • Issues arising from virtual currency exchanges, intermediaries and custodians
    • The regulatory landscape surrounding virtual currencies
    • Technological considerations
    • Transaction fees

    Trading in virtual currency derivatives

    NFA-member managers must also provide customized investor disclosures where a fund or managed account’s trading will involve virtual currency derivatives. This information would include a relevant short-form disclosure in promotional materials, and a fulsome discussion of relevant risks in applicable offering memoranda and account brochures. The NFA does not prescribe any “boilerplate” disclosure for promotional materials, offering memoranda or account brochures in the context of virtual currency derivatives trading, but does list several considerations for tailoring these disclosures. The NFA states that such disclosures should cover the “unique features” of these instruments and the potential impact that these risks may have on a fund or account’s investment program. By way of example, the NFA highlights several potential risks[6]:

    • The potential for price volatility and potential initial margin increases;
    • Potential futures commission merchant restrictions on trading in virtual currency derivatives, such as “requiring additional margin, imposing position limits, prohibiting naked shorting or prohibiting give-in transactions”; and
    • The possibility of DCM trading halts or other restrictions on trading in virtual currency derivatives that may limit a manager’s ability to exit a position when volatility is high.

    Because virtual currency derivatives are at least indirectly exposed to many of the risks inherent in virtual currencies themselves, managers who trade exclusively in virtual currency derivatives should nonetheless consider each of the NFA’s highlighted risks attendant to spot trading when crafting their disclosures.

    Action Steps

    Managers should note that the NFA has recently increased its scrutiny of members’ compliance with virtual currency disclosure obligations. Failure to comply with these requirements could subject a member to deficiencies, sanctions and a broader review of its promotional and offering materials. Accordingly, all NFA-member managers should take the time to:

    • Assess whether any fund or managed account has, or will have, direct or indirect crypto asset exposure;
    • Review NFA Interpretive Notice 9073; and
    • Confirm that their promotional materials and offering documents comply with NFA rules.

    Furthermore, while the NFA’s Virtual Currency Disclosure rules apply only to NFA members, it is advisable for managers generally to seek counsel on the adequacy of their current investor disclosures if they plan to add cryptocurrency assets to their portfolios.

    Authored by Marc E. Elovitz, Heather N. Wyckoff and Joshua B. Wright.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    [1] See NFA Interpretive Notice 9073: Disclosure Requirements for NFA Members Engaging In Virtual Currency Activities (effective Oct. 31, 2018), available here.

    [2] However, managers who are not NFA members generally should ensure that disclosures to their investors and clients adequately describe their virtual currency spot or derivatives exposure and the considerations associated therewith.

    [3] See NFA Virtual Currency Disclosure Requirements Webinar Transcript (Oct. 11, 2018), available here.

    [4] As a fallback, NFA-member managers engaged in virtual currency activities other than the spot or derivative trading addressed in this Alert must include a short, generic disclosure in any relevant marketing materials, as described in Interpretive Notice 9073 Section II.C.

    [5] See Interpretive Notice 9073, Section II.A.

    [6] See Interpretive Notice 9073, Section II.B.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2021 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Marc E. Elovitz

    Partner

    New York – 919 Third Avenue

    More insights

  • Video: Leaders Moving Business Forward with Lance Bartholomeusz of UNHCR

    Video: Leaders Moving Business Forward with Lance Bartholomeusz of UNHCR

    ARTICLE / VIDEO

    Video: Leaders Moving Business Forward with Lance Bartholomeusz of UNHCR

    August 3, 2021

    Read time: 3 min

    Overview

    During the pandemic, the UN Refugee Agency (UNHCR) has scaled up to keep refugees and internally displaced people safe across the globe.

    The Head of the Legal Affairs Service at UNHCR, Lance Bartholomeusz, explains how COVID-19 has affected the agency and the people it serves as well as how it is working to ensure that the rights of forcibly displaced people are respected, including the right to seek asylum despite border closures. He is interviewed by McDermott’s Ranajoy Basu in our latest video.

    In Leaders Moving Business Forward, we feature innovative executives who are using proactive strategies to make real progress in the face of political, economic, social and technological challenges.

    Learn more and subscribe for updates: mwe.com/moveforward


    Video: Leaders Moving Business Forward with Lance Bartholomeusz of UNHCR, McDermott 2021 (runtime: 9m20s)

    In depth
    Conclusion
    More insights

  • 2021 Amendments to Delaware Entity Statutes

    2021 Amendments to Delaware Entity Statutes

    ARTICLE / CLIENT ALERT

    2021 Amendments to Delaware Entity Statutes

    August 2, 2021

    Read time: 7 min

    Key takeaways
    Overview

    Certain amendments to the Delaware Limited Liability Company Act (DLLCA), the Delaware Revised Uniform Limited Partnership Act (DRULPA), the Delaware Revised Uniform Partnership Act (DRUPA) and the Delaware General Corporation Law (DGCL) went into effect on August 1, 2021. The most significant amendments affect Delaware limited liability companies and partnerships with respect to ratification of prior void or voidable acts, the authority to delegate rights, powers and duties and the statutory right to obtain books and records.

    Below is a brief description of these 2021 amendments.

    In depth

    RATIFICATION OF VOID OR VOIDABLE ACTS

    The DLLCA, the DRULPA and the DRUPA were each amended to provide a safe harbor procedure for the (1) ratification of acts or transactions that are void or voidable when taken and (2) waiver of a failure to comply with the terms of the limited liability company agreement or the partnership agreement that caused such acts or transactions to be void or voidable. The 2021 amendments modify the common law rule that void acts (as opposed to voidable acts) generally cannot be ratified.

    These safe harbors (adopted as new subsections under Section 18-106 of the DLLCA, Section 17-106 of the DRULPA and Section 15-202 of the DRUPA) allow ratification (or waiver of a failure to comply with the limited liability company agreement or the partnership agreement) by the persons whose approval, at the time of ratification or waiver, would be required either to (1) validly approve the void or voidable act or (2) amend the agreement in a manner to permit such an act to be validly taken. Any act or transaction ratified is given retroactive effect and deemed validly taken at the time of the act or transaction. These safe harbors do not preclude other valid means of ratification or waiver permitted by law.

    Additionally, if an amendment to a limited liability company agreement or partnership agreement to permit an otherwise void or voidable act requires notice to any persons pursuant to its terms, notice of the ratification or waiver must be given to the persons entitled to notice of the amendment and have not otherwise received notice of, or participated in, such ratification or waiver.

    The 2021 amendments also provide a procedure whereby the ratification or waiver may be challenged in the Delaware Court of Chancery by the entity, a member, a manager, a partner or any other person claiming to be substantially and adversely affected by the ratification or waiver (excluding any harm that would have resulted had the act been valid when taken).

    DELEGATION OF MANAGEMENT AUTHORITY

    Unless otherwise provided in the limited liability company agreement or partnership agreement, members, managers and partners have broad, unfettered authority to delegate (even irrevocably) their rights, powers and duties to manage and control the business. The DLLCA, the DRULPA and the DRUPA were previously amended, in response to court decisions, to clarify that the statutes should not be construed in a manner that restrict the power to delegate. In response to a separate court decision, the 2021 amendments again clarify the breadth of the delegation power, providing that a member, manager or partner may delegate any of its rights, powers or duties irrespective of whether it has a conflict of interest and, if it has a conflict of interest, the person to whom the power was delegated shall not be deemed conflicted solely by reason of such conflict of interest.

    BOOKS AND RECORDS DEMANDS

    A stockholder’s right to inspect the books and records of a Delaware corporation is limited to information that is “necessary and essential” to the stockholder’s stated purpose for such inspection. While this “necessary and essential” test was thought to also apply to books and records demands under the DLLCA, the DRULPA and the DRUPA, a recent Delaware Supreme Court case held otherwise with respect to a limited partnership where the partnership agreement did not expressly impose the “necessary and essential” test on a contractual inspection right.

    The 2021 amendments provide that the “necessary and essential” test applies to a member’s or partner’s statutory right to obtain books and records for a purpose reasonably related to their interest as a member or partner—provided that such right may be expanded or restricted in a limited liability company agreement or partnership agreement.

    STATUTORY PUBLIC BENEFIT ENTITIES

    The DLLCA and the DRULPA permit the formation of a statutory public benefit limited liability company or limited partnership, which is a for-profit entity that is intended to produce a public benefit and operate in a responsible and sustainable manner. A statutory public benefit entity is required to operate in a way that balances the pecuniary interests of the members or partners and the best interests of those materially affected by the entity’s conduct and its designated public benefit.

    The 2021 amendments require that the limited liability company agreement or partnership agreement (1) identify the entity as a statutory public benefit entity and (2) set forth the specific public benefit to be promoted, each of which the DLLCA and the DRULPA already require to be included in the entity’s certificate of formation or certificate of limited partnership. The 2021 amendments also provide that the public benefit identified in the limited liability company agreement or partnership agreement will control as among the members, managers, partners or other persons bound by the agreement in the event of an inconsistency between that public benefit and the public benefit set forth in the certificate of formation or certificate of limited partnership (and the certificate must be promptly amended if a manager, member or general partner becomes aware that the public benefit stated therein is inaccurate).

    Additionally, the 2021 amendments provide a mechanism to allow an existing entity to become a statutory public benefit entity by either (1) amending its certificate of formation or certificate of limited partnership and its limited liability company agreement or partnership agreement to comply with the DLLCA or the DRULPA or (2) complying with the requirements, if any, in its limited liability company agreement or partnership agreement.

    GENERAL PARTNERSHIP OPT-OUTS

    The DRUPA was amended to clarify that, unless otherwise provided in the partnership agreement, a Delaware general partnership that has modified one or more of the DRUPA’s default rules (such as the rule that a partnership is a separate legal entity) in its partnership agreement and a statement of partnership existence or statement of qualification shall continue to be governed by all other provisions of the DRUPA.

    This amendment is in response to a Delaware Supreme Court holding that a Delaware limited liability partnership, which opted out of separate entity status, was dissolved when one of the partners withdrew and a new partner admitted, notwithstanding a provision in the partnership agreement pursuant to which a withdrawal of a partnership would not cause the dissolution of the partnership.

    STOCK COUNTED FOR QUORUM AND VOTING

    The DGCL was amended to clarify that shares of a corporation’s stock held by another entity cannot be voted or counted for quorum purposes if the corporation either directly or indirectly holds a majority of such other entity’s voting power or if the corporation directly or indirectly controls such other entity.

    Authors

    Nathan E. Barnett

    Partner

    Wilmington

    Benjamin Strauss

    Partner

    Wilmington

    More insights

  • FTC Looks to Fix Repair Restrictions

    FTC Looks to Fix Repair Restrictions

    ARTICLE / CLIENT ALERT

    FTC Looks to Fix Repair Restrictions

    August 2, 2021

    Read time: 5 min

    Key takeaways
    Overview

    A newly announced change in Federal Trade Commission (FTC) policy could have dramatic implications for the ways manufacturers of everything from cell phones to cars draft warranties, design products, and distribute replacement parts. Specifically, the FTC has set its sights on repair restrictions.

    In depth

    On July 21, the Commission unanimously voted to approve a policy statement announcing increased antitrust and consumer protection enforcement against business practices that make it difficult for consumers to repair their own products, or use independent repair shops. Manufacturers should take note of this import change in enforcement policy, and promptly evaluate their exposure.

    Notably, the FTC’s announcement comes on the heels of President Biden’s executive order “Promoting Competition in the American Economy,” which encouraged the FTC to address “anticompetitive restrictions on third-party repair or self-repair of items…” It also follows a recent report by the FTC to Congress addressing repair restrictions, and a July 2019 FTC workshop examining the issue.

    One area of particular concern for the FTC is product warranties that require the use of specific service providers or parts. Section 102(c) of a 1975 federal law known as the Magnuson-Moss Warranty Act (MMWA) prohibits companies from conditioning warranty coverage, expressly or impliedly, on a consumer’s use of an article or service identified by brand, trade, or corporate name, unless the company provides that article or service without charge or the company has received a waiver from the FTC.

    Recent reports, including empirical analyses cited by the FTC in its report to Congress, suggest that violations of Section 102(c) are widespread. Indeed, one recent analysis by a prominent public interest group alleged that 45 out of 50 companies whose warranties the group examined appeared to violate the provision. Accordingly, Section 102(c) enforcement is likely to play a prominent role in the FTC’s crackdown.

    It also appears that the FTC intends to use its broad authority under Section 5 of the FTC Act, which prohibits “unfair or deceptive acts or practices,” to challenge a wide range repair restrictions. In its report to Congress, the FTC highlighted the following practices in particular as “restricting independent repair or repair by consumers:”

    • “Physical restrictions” and “product designs that complicate or prevent repair”;
    • Purposely making parts, repair manuals, and diagnostic software and tools unavailable;
    • Designs that make independent repairs less safe, such as the use of glue to fasten lithium ion cells into mobile phones and other devices;
    • Steering consumers to preferred repair networks using telematics;
    • “Policies or statements that steer consumers to manufacturer repair networks”;
    • “Application of patent rights and enforcement of trademarks;
    • Disparagement of non-OEM parts and independent repair”;
    • “Software locks, Digital Rights Management and Technical Protection Measures”; and
    • “End User License Agreements.”

    The diverse range of practices that the FTC has identified make this shift in enforcement an important issue for a wide range of companies. Still, there are clues to how the FTC may deploy its scarce resources in this area, at least initially.

    First, its prior enforcement may provide an indication. In 2015, the FTC approved a complaint and settlement against a leading car manufacturer. In 2018, the FTC issued several warning letters to companies marketing cars, cellular devices, and video gaming systems. Companies in those industries can reasonably expect to be early targets of this new enforcement push and should move swiftly to shore up their compliance.

    Second, the President’s Executive Order and related “Fact Sheet” specifically address repair restrictions in the agricultural industry, particularly by tractor manufacturers. And, the FTC’s report to Congress repeatedly mentioned tractors repair restrictions. Accordingly, agricultural equipment manufacturers should also expect to be an early enforcement target of the FTC.

    Third, at least three states—Rhode Island, Indiana, and California—have existing “right to repair” statutes, and many other states are considering such laws. Companies operating in those states should be prepared to face investigations conducted jointly by state attorneys general and the FTC.

    This shift in FTC enforcement policy may have a dramatic effect on a wide range of manufacturers. Companies should evaluate their warranties and related business practices now and take the opportunity to improve compliance before the FTC comes knocking. Equally important, companies who may wish to defend and maintain existing repair restrictions should begin working with counsel immediately to prepare their strategy.

    Authors
    More insights

  • CMS Issues Favorable Advisory Opinion, Clarifying the “Single Legal Entity” Requirement

    ARTICLE / CLIENT ALERT

    CMS Issues Favorable Advisory Opinion, Clarifying the “Single Legal Entity” Requirement

    July 30, 2021

    Read time: 6 min

    Key takeaways
    Overview

    In June 2021, the Centers for Medicare & Medicaid Services (CMS) published a favorable advisory opinion (AO), indicating that a physician practice could qualify as a “group practice” under the physician self-referral law (the Stark Law) if it furnishes designated health services (DHS) through a wholly-owned subsidiary entity that is a physician practice. This AO clarifies that a physician practice that otherwise qualifies as a “group practice” may operate, furnish and bill for DHS through a wholly-owned subsidiary entity that is a physician practice but does not itself qualify as a “group practice.”

    In depth

    BACKGROUND

    Generally, the Stark Law prohibits a “physician” from “referring” Medicare beneficiaries to an “entity” for the furnishing of DHS if the physician (or one of their immediate family members) has a “financial relationship” with the entity (DHS Entity)—unless a statutory or regulatory exception applies (the Stark Law’s “referral prohibition”). The Stark Law also prohibits the DHS Entity from billing Medicare or any other person or entity for improperly referred DHS (the Stark Law’s “billing prohibition”). DHS includes 10 categories of services, including clinical laboratory services, radiology and other imaging services.

    One of the most frequently used exceptions for physician practices is for in-office ancillary services (IOAS Exception). The IOAS Exception generally is available to a physician practice consisting of two or more physicians only if the physician practice qualifies as a “group practice.” A “group practice” must consist of a “single legal entity” operating primarily for the purpose of being a physician group practice. The group practice definition further stipulates that the single legal entity may be organized or owned by another medical practice, provided that the other medical practice is not an operating physician practice (regardless of whether the medical practices meets the conditions of being a group practice). The regulations also state that a group practice that is otherwise a single legal entity may itself own subsidiary entities but do not specify whether the subsidiary may be a medical practice. Prior to this AO, CMS specifically referenced the ability of a group practice to own and operate other legal entities—such as a laboratory—for purposes of providing services to the group practice but had not opined as to whether such a subsidiary entity could itself be enrolled as an operating physician practice.

    A CLOSER LOOK AT THE ADVISORY OPINION

    The request for an AO was submitted by a group practice (Group) that owned and operated separately-enrolled Medicare physician practices (Subsidiaries) located in separate states. CMS provided a favorable AO indicating that furnishing DHS through the Subsidiaries—each enrolled as a physician practice—would not prevent the Group from qualifying as a “group practice.”

    The Group certified that all clinical employees and contractors of the Subsidiaries would be employed or contracted by the Group and assigned to work at the Subsidiaries. The favorable AO permits each Subsidiary of the Group to remain a Medicare-enrolled practice and maintain its existing contracts with payors and health plans, including billing Medicare for DHS. The Group also certified that all revenues and expenses of the Subsidiaries would be treated as revenue and expenses of the Group, and patients seen by the Subsidiaries would be considered patients of the Group.

    CMS emphasized that the requirement for a “group practice” to be a “single legal entity” expressly permits a group practice to own subsidiaries and, although CMS previously provided only the example of a laboratory wholly-owned by a group practice, this does not prevent a group practice from furnishing other services—including physicians’ professional services to its patients through other types of wholly-owned subsidiaries.

    In dicta, CMS noted that a group practice must “primarily provide services of the type provided by a supplier that is enrolled in Medicare as a clinic/group practice.” This language serves to highlight that, although a group practice may own and operate subsidiary entities to furnish services to its patients, the group must remain, at its core, a physician practice, and cannot utilize the IOAS Exception to circumvent the referral prohibition of the Stark Law by establishing subsidiary entities that are not central to group practice’s services to patients.

    PRACTICAL IMPLICATIONS

    For purposes of physician practice acquisitions, the AO clarifies that an existing physician practice platform that is acquiring a physician practice may maintain the existing practice legal entity of the acquisition target, significantly easing the burden of transferring payor contracts and provider credentialing from the acquired practice to the acquirer. This AO provides clear guidance surrounding an additional pathway to structure physician practice acquisitions. The structure contemplated by this AO may be particularly useful when a physician practice is acquiring a practice in a new state in which the acquirer does not have existing payor contracts. This eases one of the most significant burdens in the physician practice industry: The operational and payor disruption that accompanies combining physician practice operations into one taxpayer identification number (TIN), which has long been the industry practice for purposes of meeting the definition of a “group practice.”

    Although CMS provided a favorable opinion surrounding satisfaction of the single legal entity prong of the group practice definition, all other elements of the “group practice” definition must still be met for the relevant group practice to satisfy the IOAS Exception. In particular, a physician practice must operate as a “unified business” with centralized decision-making, consolidated billing, accounting and financial reporting. When structuring a group practice that intends to rely on subsidiary entities, extra care should be taken to ensure the “unified business” requirement is satisfied by the physician practice for purposes of Stark Law compliance.

    Authors

    Amanda Jester

    Partner

    Austin

    Caroline Reignley

    Partner

    Washington, DC

    More insights

  • CMS Seeks Comments on Requirements for Rural Emergency Hospitals as a New Medicare Provider Category

    CMS Seeks Comments on Requirements for Rural Emergency Hospitals as a New Medicare Provider Category

    ARTICLE / CLIENT ALERT

    CMS Seeks Comments on Requirements for Rural Emergency Hospitals as a New Medicare Provider Category

    July 30, 2021

    Read time: 8 min

    Key takeaways
    Overview
    In depth

    Background

    Under current Medicare program rules, Medicare does not recognize “freestanding emergency departments” or other non-hospital providers of emergency department services. Medicare will only pay for these services at facilities that meet the Medicare definition of “hospital,” which requires the provision of inpatient services, among other requirements that are often difficult for low-volume facilities to meet. This limitation has presented particular challenges for rural communities, where there may be insufficient patient volume or resources to support inpatient services, but where access to emergency services and higher-level outpatient services is still necessary and may otherwise require travel to distant communities.

    Congress established REHs in the Consolidated Appropriations Act of 2021 to help address this gap in Medicare rules. While the new statutory provision provides a detailed framework for the REH provider type, key details of REH services and participation requirements were left to CMS to develop through regulations and guidance. In connection with the 2022 Hospital Outpatient Prospective Payment System, CMS issued a request for information focusing on the health and safety standards, quality measures and reporting requirements, and payment policies that should apply to REHs. CMS also seeks broad input on the concerns of rural providers that should be taken into consideration as CMS implements the program participation requirements for REHs.

    For additional background on the REH statute, please see our prior On the Subject.

    In Depth

    CMS seeks input on a wide variety of topics related to development of REH regulations, including the type and scope of services that may be offered by REHs, licensure and conditions of participation (CoPs), and the payment rules that will implement the statutory payment methodology.

    CMS specifically requests input and comments on the following questions and concepts:

    1. What are the barriers and challenges to delivering emergency department services customarily provided by hospitals and critical access hospitals (CAHs) in rural and underserved communities that may require different or additional CoPs for REHs (for example, staffing shortages, transportation and sufficient resources)?
    2. An REH must provide emergency and observation services and may elect to provide additional services as determined appropriate by the Secretary. What other outpatient medical and health services, including behavioral health services, should the Secretary consider as additional eligible services? In particular, what other services may otherwise have a lack of access for Medicare beneficiaries if an REH does not provide them?
    3. What, if any, virtual or telehealth services would be appropriate for REHs to provide, and what role could virtual care play in REHs?
    4. Should REHs include Opioid Treatment Programs, clinics for buprenorphine induction, or clinics for treating stimulant addiction in their scope of services? Please discuss the barriers that could prevent inclusion of each of these types of services.
    5. What, if any, maternal health services would be appropriate for REHs to provide, and how can REHs address the maternal health needs in rural communities? What unique challenges or concerns will the provision of care to the maternal health population present for an REH?
    6. The statute requires that REHs meet the requirements for emergency services (set forth at § 485.618) that apply to CAHs. Which hospital emergency department requirements (set forth at § 482.55) should or should not be mandated for REHs, and why or why not? Are there additional health and safety standards that should be considered? What are they, why are they important, and are there data that speak to the need for a particular standard?
    7. REHs must meet staff training and certification requirements established by the Secretary. Should these be the same as, or similar to, CAH requirements (Personnel qualifications, §485.604 and Staffing and staff responsibilities, §485.631)? Are there additional or different staff training and certification requirements that should be considered for REHs, and why? Are there any staffing concerns that the existing CAH requirements would not address?
    8. What additional considerations should CMS be aware of as it evaluates the establishment of CoPs for REHs? Are there data and/or research of which CMS should particularly be aware?
    9. What, if any, lessons have been learned regarding rural emergency services during the COVID-19 pandemic that might be pertinent for policy implementation after the public health emergency?
    10. Are there state licensure concerns for hospitals and CAHs that wish to become REHs? What issues with respect to existing or potential state licensure requirements should CMS consider when developing the CoPs for this new provider type? What supports and timelines should be in place for states to establish licensing rules?

      Consistent with the Biden administration’s executive orders aimed at addressing health equity concerns, CMS also seeks comment on the following issues:

    11. How can REHs address the social needs arising in rural areas from challenging social determinants of health (the conditions in which people are born, live, learn, work, play, worship and age, which can have a profound impact on patients’ health), and how should REHs be held accountable for health equity?
    12. With respect to questions 1 through 11, are there additional factors CMS should consider for specific populations, including, but not limited to, elderly and pediatric patients; homeless persons; racial, ethnic, sexual or gender minorities; veterans; and persons with physical, behavioral (for example, mental health conditions and substance use disorders), and/or intellectual and developmental disabilities?
    13. How can the CoPs ensure that an REH’s executive leadership (that is, its governance, or persons legally responsible for the REH) is fully invested in and held accountable for implementing policies that will reduce health disparities within the facility and the community that it serves? In addition, with regards to governance and leadership, how can the CoPs:
      • Encourage an REH’s executive leadership to use diversity and inclusion strategies to establish a diverse workforce that is reflective of the community that it serves?
      • Ensure that health equity is embedded into a facility’s strategic planning and quality improvement efforts?
      • Ensure that executive leadership is held accountable for reducing health disparities?
    14. An important first step in addressing health disparities and improving health outcomes is to consider a patient’s post-discharge needs and social determinants of health prior to discharge from a facility. How can health equity be advanced through the care planning and discharge planning process? How can the CoPs address the need for REHs to partner with community-based organizations to improve a patient’s care and outcomes after discharge?
    15. In order to ensure that healthcare workers understand and incorporate health equity concepts as they provide culturally competent care to patients, and in order to mitigate potential implicit and explicit bias that may exist in healthcare, what types of staff training or other efforts would be helpful?
    16. How can the CoPs ensure that providers offer fully accessible services for their patients in terms of physical, communication and language access with the resources they have available to them?

    CMS also seeks comment on the quality measurement and reporting requirements mandated by the Consolidated Appropriations Act, including:

    • What current quality measures in rural care should be recommended or developed? What are likely quality barriers and challenges?
    • What barriers and challenges to electronic submissions of quality measures would apply to REHs?
    • What factors should be considered for the baseline measure set of an REH and how might quality measures support survey and certification of REHs?
    • What incentives or disincentives for quality reporting unrelated to payment would be appropriate for REHs, and should they depend on patient volume or mix or geographic distance?
    • How should CMS report REH quality measure data?

    Practical Implications

    New provider types are seldom introduced to the Medicare program, and the creation of REHs offers a rare opportunity for expansion of the locations and types of services covered by Medicare. Stakeholders should not miss this opportunity to influence the policy that will determine the health and safety standards that will be applicable to REHs. The depth and breadth of the questions that CMS has provided for comment indicate that CMS is evaluating many aspects of the REH model for rulemaking and guidance, and that CMS believes it has wide flexibility under the statute to determine how REHs ultimately operate in practice. Factors under consideration include not just the CoPs that an REH must meet in order to enroll in Medicare, but other key areas such as what services an REH may provide, what services an REH can be paid for under Medicare (and under what methodology), quality reporting standards and reporting requirements.

    Responses to the current requests for information can be submitted to CMS electronically at http://www.regulations.gov or by mail no later than September 13, 2021. CMS intends to use comments received in response to this request for information to develop a proposed rule to implement this new provider type. This will provide stakeholders with an additional, but more limited, opportunity to submit comments after publication of CMS’s proposed rule. CMS is obligated to propose and finalize regulations establishing and governing REHs in time for the statutorily required effective date of January 1, 2023.

    Authors

    Emily Jane Cook

    Partner

    Los Angeles, Washington, DC

    Sandra M. DiVarco

    Partner

    Chicago

    Caroline Reignley

    Partner

    Washington, DC

    More insights

  • California Requires Vaccines or Regular COVID-19 Testing for Certain Healthcare Workers and State Employees

    California Requires Vaccines or Regular COVID-19 Testing for Certain Healthcare Workers and State Employees

    ARTICLE / CLIENT ALERT

    California Requires Vaccines or Regular COVID-19 Testing for Certain Healthcare Workers and State Employees

    July 29, 2021

    Read time: 5 min

    Key takeaways
    Overview

    UPDATE:

    This article has been updated pursuant to further guidance issued by the California Department of Public Health (CDPH) on August 9, 2021, and September 3, 2021.

    On July 26, 2021, the CDPH issued a new Order that impacts healthcare and state employers in California. The CDPH Order requires that almost all healthcare employers verify the vaccination status of all of their workers. The Order also requires workers who are not fully vaccinated (unvaccinated) to go through regular COVID-19 testing at specified intervals. These facilities also must have a plan in place for tracking verified worker vaccination statuses.

    In depth

    “FULLY VACCINATED”

    Individuals are considered “fully vaccinated” two weeks or more after the second shot of the two-dose vaccines (Pfizer-BioNTech, Moderna or a vaccine authorized by the World Health Organization (WHO)) or two weeks or more after they have received a single-dose vaccine (Johnson and Johnson). Individuals must also have verified their vaccination status with the facility via a mode approved by the CDPH discussed further below.

    WHAT WORKERS DOES THIS APPLY TO?

    In the Order, “worker” is broadly defined to include (but is not limited to) the following: nurses, nursing assistants, physicians, technicians, therapists, phlebotomists, pharmacists and students and trainees. It also applies to contractual staff not employed by the healthcare facility as well as persons not directly involved in patient care but who could be exposed to infectious agents that can be transmitted in the healthcare setting (e.g., clerical, dietary, environmental services, laundry, security, engineering and facilities management, administrative, billing and volunteer personnel).

    WHO THE ORDER APPLIES TO

    The following Acute Health Care and Long-Term Care facilities must test unvaccinated workers at least biweekly and must provide them with respirators:

    1. General Acute Care Hospitals

    2. Skilled Nursing Facilities (including Subacute Facilities)

    3. Intermediate Care Facilities

    Facilities in “High-Risk Congregate Settings” and other “Health Care Settings” must test unvaccinated workers at least weekly; these facilities must also provide unvaccinated workers with surgical masks. The following are covered by these requirements:

    1. Adult and Senior Care Facilities

    2. Homeless Shelters

    3. State and Local Correctional Facilities and Detention Centers

    4. Acute Psychiatric Hospitals

    5. Adult Day Health Care Centers

    6. Adult Day Programs Licensed by the California Department of Social Services

    7. Program of All-Inclusive Care for the Elderly (PACE) and PACE Centers

    8. Ambulatory Surgery Centers

    9. Chemical Dependency Recovery Hospitals

    10. Clinics & Doctor Offices (including behavioral health, surgical)

    11. Congregate Living Health Facilities

    12. Dental Offices

    13. Dialysis Centers

    14. Hospice Facilities

    15. Pediatric Day Health and Respite Care Facilities

    16. Residential Substance Use Treatment and Mental Health Treatment Facilities

    WHO THE ORDER DOES NOT APPLY TO

    In guidance published on August 9, 2021, CDPH published further guidance on certain questions left open by the initial July 26, 2021 Order. TCDPH has clarified that the following facilities and/or offices are not covered under the Order:

    1. Acupuncture offices

    2. Chiropractic offices

    3. Naturopathic doctor offices

    4. Occupational therapy offices

    5. Optometry offices

    6. Outpatient physical, speech and occupational therapy offices

    7. Pharmacies

    8. Podiatry offices

    9. First aid offices (e.g., at a resort or theme park)

    10. Autism Centers (and the Applied Behavior Analyst)

    HOW TO VERIFY VACCINATION STATUS

    The Order specifies the approved modes of vaccination verification, which include:

    1. A COVID-19 vaccination record card issued by the US Centers for Disease Control and Prevention, or a WHO Yellow Card that includes the name of the person vaccinated, the type of vaccine provided and the date that the last dose was administered;

    2. A photo of a vaccination record card as a separate document;

    3. A photo of the vaccination record card stored on a phone or electronic device;

    4. Documentation of a COVID-19 vaccination from a healthcare provider;

    5. A digital record that includes a QR code that when scanned by a SMART Health Card reader displays the reader client name, date of birth, vaccine dates and vaccine type (the QR code must also confirm the vaccine record as an official record of the state of California); OR

    6. Documentation of vaccination from other contracted employers who follow these vaccination records guidelines and standards.

    TESTING MUST BE FREE FOR WORKERS

    CDPH has provided further clarification that health plans are obligated to cover the cost of COVID-19 testing in these settings. Moreover, health insurers are also required to waive cost sharing amounts for certain COVID-19 related screening and testing.

    The Department of Health Care Services (DHCS) also covers both COVID-19 viral and serologic (antibody) tests at no cost to Medi-Cal beneficiaries. Pursuant to CDPH guidance, this includes all medically necessary viral and serologic testing as well as serologic (antibody) tests ordered for infection control purposes (e.g., pre-operative screening or planned hospitalizations).

    Practically speaking, to the extent any unforeseen reasonable and necessary costs are incurred by the employee when obtaining required COVID-19 testing, the employer may be obligated to reimburse such expenses pursuant to California Labor Code section 2802.

    DEADLINE FOR COMPLIANCE

    This Order goes into effect on August 9, 2021, at 12:01 am. Facilities must be in full compliance by August 23, 2021.

    The full Order is found here: https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/COVID-19/Order-of-the-State-Public-Health-Officer-Unvaccinated-Workers-In-High-Risk-Settings.aspx

    Authors
    More insights